BURNEY CO/ - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 6.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
BURNEY CO/ ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$37,800
-16.3%
35,0000.0%0.00%0.0%
Q2 2023$45,150
-2.3%
35,0000.0%0.00%0.0%
Q1 2023$46,200
-12.0%
35,0000.0%0.00%
-33.3%
Q4 2022$52,500
+28.0%
35,0000.0%0.00%
+50.0%
Q3 2022$41,000
+13.9%
35,000
+9.4%
0.00%0.0%
Q2 2022$36,000
-62.5%
32,0000.0%0.00%
-50.0%
Q1 2022$96,000
+12.9%
32,0000.0%0.00%0.0%
Q4 2021$85,000
-26.7%
32,0000.0%0.00%
-20.0%
Q3 2021$116,000
-16.5%
32,0000.0%0.01%
-16.7%
Q2 2021$139,000
+27.5%
32,0000.0%0.01%
+20.0%
Q1 2021$109,000
-2.7%
32,0000.0%0.01%
-16.7%
Q4 2020$112,000
+45.5%
32,0000.0%0.01%
+20.0%
Q3 2020$77,000
+30.5%
32,0000.0%0.01%
+25.0%
Q2 2020$59,000
+18.0%
32,0000.0%0.00%0.0%
Q1 2020$50,000
-26.5%
32,0000.0%0.00%0.0%
Q4 2019$68,000
-4.2%
32,000
+28.0%
0.00%0.0%
Q2 2018$71,000
-26.8%
25,0000.0%0.00%
-20.0%
Q4 2017$97,00025,0000.01%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
CM Management, LLC 1,500,000$1,620,0001.72%
Soleus Capital Management, L.P. 14,803,015$15,987,2561.48%
ARMISTICE CAPITAL, LLC 17,136,000$18,506,8800.28%
SPHERA FUNDS MANAGEMENT LTD. 1,228,126$1,326,3760.24%
GSA CAPITAL PARTNERS LLP 971,441$1,0490.09%
NJ State Employees Deferred Compensation Plan 200,000$216,0000.03%
Providence Wealth Advisors, LLC 27,500$29,0130.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,151,765$1,243,9060.03%
XTX Topco Ltd 164,238$177,3770.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 3,369,076$3,638,6020.02%
View complete list of RIGEL PHARMACEUTICALS INC shareholders